• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度泰米尔纳德邦帕金森病患者的基因表型分析、代谢组学分析及临床相关性研究。

Genotypic-Phenotypic Analysis, Metabolic Profiling and Clinical Correlations in Parkinson's Disease Patients from Tamil Nadu Population, India.

机构信息

Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore, 641 046, Tamil Nadu, India.

Livestock Farming, & Bioresources Technology, Tamil Nadu, India.

出版信息

J Mol Neurosci. 2022 Aug;72(8):1724-1737. doi: 10.1007/s12031-022-02028-4. Epub 2022 Jun 8.

DOI:10.1007/s12031-022-02028-4
PMID:35676593
Abstract

Parkinson's disease (PD) is an ageing disorder caused by dopaminergic neuron depletion with age. Growing research in the field of metabolomics is expected to play a major role in PD diagnosis, prognosis and therapeutic development. In this study, we looked at how SNCA and GBA1 gene mutations, as well as metabolomic abnormalities of kynurenine and cholesterol metabolites, were linked to alpha-synuclein (α-syn) and clinical characteristics in three different PD age groups. In all three age groups, a metabolomics analysis revealed an increased amount of 27-hydroxycholesterol (27-OHC) and a lower level of kynurenic acid (KYNA). The effect of 27-OHC on SNCA and GBA1 modifications was shown to be significant (P < 0.05) only in the A53T variant of the SNCA gene in late-onset and early-onset PD groups, whereas GBA1 variants were not. Based on the findings, we observed that the increase in 27-OHC would have elevated α-syn expression, which triggered the changes in the SNCA gene but not in the GBA1 gene. Missense variations in the SNCA and GBA1 genes were investigated using the sequencing technique. SNCA mutation A53T has been linked to increased PD symptoms, but there is no phenotypic link between GBA1 and PD. As a result of the data, we hypothesise that cholesterol and kynurenine metabolites play an important role in PD, with the metabolite 27-OHC potentially serving as a PD biomarker. These findings will aid in the investigation of pathogenic causes as well as the development of therapeutic and preventative measures for PD.

摘要

帕金森病(PD)是一种衰老性疾病,由多巴胺能神经元随年龄增长而耗竭引起。代谢组学领域的研究不断深入,有望在 PD 的诊断、预后和治疗开发中发挥重要作用。在这项研究中,我们研究了 SNCA 和 GBA1 基因突变以及色氨酸和胆固醇代谢物的代谢组学异常与α-突触核蛋白(α-syn)和三个不同 PD 年龄组的临床特征之间的关系。在所有三个年龄组中,代谢组学分析显示 27-羟胆固醇(27-OHC)的含量增加,而犬尿氨酸酸(KYNA)的水平降低。结果表明,只有在晚发型和早发型 PD 组的 SNCA 基因 A53T 变异中,27-OHC 对 SNCA 和 GBA1 修饰的影响才具有统计学意义(P<0.05),而 GBA1 变体则没有。根据这些发现,我们观察到 27-OHC 的增加会导致α-syn 表达升高,从而触发 SNCA 基因的变化,但不会触发 GBA1 基因的变化。使用测序技术研究了 SNCA 和 GBA1 基因的错义变异。SNCA 基因的 A53T 突变与 PD 症状的增加有关,但 GBA1 与 PD 之间没有表型联系。基于这些数据,我们假设胆固醇和犬尿氨酸代谢物在 PD 中起重要作用,代谢物 27-OHC 可能作为 PD 的生物标志物。这些发现将有助于研究发病原因以及开发 PD 的治疗和预防措施。

相似文献

1
Genotypic-Phenotypic Analysis, Metabolic Profiling and Clinical Correlations in Parkinson's Disease Patients from Tamil Nadu Population, India.印度泰米尔纳德邦帕金森病患者的基因表型分析、代谢组学分析及临床相关性研究。
J Mol Neurosci. 2022 Aug;72(8):1724-1737. doi: 10.1007/s12031-022-02028-4. Epub 2022 Jun 8.
2
DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with Mutations.α-突触核蛋白内含子 1 的 DNA 甲基化在携带突变的帕金森病患者的额皮质中显著降低。
Int J Mol Sci. 2023 Jan 31;24(3):2687. doi: 10.3390/ijms24032687.
3
Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.GBA1 突变对多巴胺能神经元蛋白稳态的变异特异性影响。
J Neurochem. 2024 Sep;168(9):2543-2560. doi: 10.1111/jnc.16114. Epub 2024 Apr 20.
4
Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.帕金森病 hPSC 模型中的轴突病变是由于 Map1b 基因座处 Nrf2 转录活性的丧失导致的。
Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14280-14289. doi: 10.1073/pnas.1900576116. Epub 2019 Jun 24.
5
Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.多巴胺能神经元中的葡萄糖脑苷脂酶缺乏会诱导小胶质细胞活化而不发生神经退行性变。
Hum Mol Genet. 2017 Jul 15;26(14):2603-2615. doi: 10.1093/hmg/ddx120.
6
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.脑内给予配体-ASO 缀合物可选择性降低双突变人 A30P*A53T*α-突触核蛋白转基因小鼠单胺能神经元中 α-突触核蛋白的积累。
Int J Mol Sci. 2021 Mar 13;22(6):2939. doi: 10.3390/ijms22062939.
7
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease .CRISPR-Cas9 基因编辑可预防 A53T-SNCA 过表达诱导的帕金森病病理
CRISPR J. 2022 Feb;5(1):95-108. doi: 10.1089/crispr.2021.0025.
8
Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.帕金森病和多系统萎缩大脑中 α-突触核蛋白(SNCA)的体细胞拷贝数增加。
Brain. 2018 Aug 1;141(8):2419-2431. doi: 10.1093/brain/awy157.
9
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.帕金森病患者(PARK4)中 SNCA 三重复制诱导多能干细胞源性多巴胺能神经元中的α-突触核蛋白动力学。
FEBS Open Bio. 2021 Feb;11(2):354-366. doi: 10.1002/2211-5463.13060. Epub 2021 Jan 5.
10
GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers.GBA1 缺乏会对生理 α-突触核蛋白四聚体及相关多聚体产生负面影响。
Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):798-803. doi: 10.1073/pnas.1700465115. Epub 2018 Jan 8.

引用本文的文献

1
Association Study Between Kynurenine 3-Monooxygenase (KMO) Gene and Parkinson's Disease Patients.色氨酸 3-单加氧酶(KMO)基因与帕金森病患者的关联研究。
Mol Neurobiol. 2024 Jul;61(7):3867-3881. doi: 10.1007/s12035-023-03815-9. Epub 2023 Dec 1.
2
Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach.2 型糖尿病(T2DM)与帕金森病(PD):一种基于机制的研究方法。
Mol Neurobiol. 2023 Aug;60(8):4547-4573. doi: 10.1007/s12035-023-03359-y. Epub 2023 Apr 28.
3
Influence of heavy metals in Parkinson's disease: an overview.

本文引用的文献

1
Mitochondrial dysfunction: A hidden trigger of autism?线粒体功能障碍:自闭症的一个隐藏诱因?
Genes Dis. 2020 Jul 16;8(5):629-639. doi: 10.1016/j.gendis.2020.07.002. eCollection 2021 Sep.
2
The association between multiple risk factors, clinical correlations and molecular insights in Parkinson's disease patients from Tamil Nadu population, India.印度泰米尔纳德邦帕金森病患者的多种风险因素、临床相关性和分子见解之间的关联。
Neurosci Lett. 2021 Jun 11;755:135903. doi: 10.1016/j.neulet.2021.135903. Epub 2021 Apr 21.
3
Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
重金属对帕金森病的影响:综述。
J Neurol. 2022 Nov;269(11):5798-5811. doi: 10.1007/s00415-022-11282-w. Epub 2022 Jul 28.
代谢组学分析揭示了脂质代谢的改变,并确定了一组脂质代谢物作为帕金森病相关焦虑障碍的生物标志物。
Neurosci Lett. 2021 Feb 6;745:135626. doi: 10.1016/j.neulet.2021.135626. Epub 2021 Jan 10.
4
Lipid metabolic dysregulation is involved in Parkinson's disease dementia.脂代谢失调与帕金森病痴呆有关。
Metab Brain Dis. 2021 Mar;36(3):463-470. doi: 10.1007/s11011-020-00665-5. Epub 2021 Jan 12.
5
Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease.色氨酸代谢物与帕金森病的症状和黑质病理有关。
Mov Disord. 2020 Nov;35(11):2028-2037. doi: 10.1002/mds.28202. Epub 2020 Jul 25.
6
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.代谢综合征并不影响 LRRK2 和 GBA 相关帕金森病的表型。
Sci Rep. 2020 Jun 9;10(1):9329. doi: 10.1038/s41598-020-66319-9.
7
Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?解析多巴胺转运体(DAT)和 Parkin 在帕金森病(PD)中的相关作用——探索之路?
Brain Res Bull. 2020 Apr;157:169-179. doi: 10.1016/j.brainresbull.2020.02.001. Epub 2020 Feb 6.
8
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.帕金森病双突变人 A30P*A53Tα-突触核蛋白转基因小鼠模型的行为和多巴胺能变化。
Sci Rep. 2019 Nov 22;9(1):17382. doi: 10.1038/s41598-019-54034-z.
9
Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease.帕金森病患者脑脊液中犬尿氨酸及其代谢物代谢受损。
Neurosci Lett. 2020 Jan 1;714:134576. doi: 10.1016/j.neulet.2019.134576. Epub 2019 Oct 22.
10
Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病中犬尿氨酸通路的年龄和疾病特异性变化。
J Neurochem. 2019 Dec;151(5):656-668. doi: 10.1111/jnc.14843. Epub 2019 Aug 25.